These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 6172517

  • 1. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T, Richert JR, Driscoll BF, Kies MW, Alvord EC.
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA, Swanborg RH.
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [Abstract] [Full Text] [Related]

  • 3. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH, Swanborg RH.
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [Abstract] [Full Text] [Related]

  • 4. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR, Driscoll BF, Kies MW, Alvord EC.
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S, Kibler RF, Morrison DC.
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [Abstract] [Full Text] [Related]

  • 6. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH, Silberg D, Swanborg RH.
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [Abstract] [Full Text] [Related]

  • 7. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ, Roberts CM, Waxman FJ.
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [Abstract] [Full Text] [Related]

  • 8. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
    Wegmann KW, Hinrichs DJ.
    J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
    [Abstract] [Full Text] [Related]

  • 9. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA, Gill T, Offner H.
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [Abstract] [Full Text] [Related]

  • 10. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
    Raziuddin S, Kibler RF, Morrison DC.
    J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
    [Abstract] [Full Text] [Related]

  • 11. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
    Driscoll BF, Kies MW, Alvord EC.
    J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
    [Abstract] [Full Text] [Related]

  • 12. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
    Panitch HS, McFarlin DE.
    J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
    [Abstract] [Full Text] [Related]

  • 13. Protection against experimental allergic encephalomyelitis with peptides derived from myelin basic protein: presence of intact encephalitogenic site is essential.
    Driscoll BF, Kies MW, Alvord EC.
    J Immunol; 1976 Jul; 117(1):110-4. PubMed ID: 58930
    [Abstract] [Full Text] [Related]

  • 14. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
    Matsumoto Y, Kawai K, Tomita Y, Fujiwara M.
    Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
    [Abstract] [Full Text] [Related]

  • 15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H, Zhang H, Liu F, Qi Y, Jiang H.
    Immunol Lett; 2014 Feb; 157(1-2):38-44. PubMed ID: 24220208
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP, Schroder K, Powell HC, Kelly CJ.
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [Abstract] [Full Text] [Related]

  • 17. The nature of the defect in experimental allergic encephalomyelitis (EAE)-resistant Lewis (Le-R) rats.
    Driscoll BF, Kies MW, Alvord EC.
    J Immunol; 1985 Mar; 134(3):1567-70. PubMed ID: 2578512
    [Abstract] [Full Text] [Related]

  • 18. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
    Hayosh NS, Simon LL, Swanborg RH.
    J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
    [Abstract] [Full Text] [Related]

  • 19. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat.
    Hunt DW, Corson L, Barker HD, Levy JG, Petty RE.
    J Autoimmun; 1993 Dec; 6(6):691-700. PubMed ID: 8155251
    [Abstract] [Full Text] [Related]

  • 20. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
    Welch AM, Holda JH, Swanborg RH.
    J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.